Patent cliff causes negative outlook for global pharma | Healthcare Finance News

November 1, 2012

The outlook for the global pharmaceutical industry remains negative as any potential revenue over the next 12-18 months is likely to be offset by losses from the upcoming expirations of major patents -  known as the patent cliff -  according to a new industry report by Moody’s Investors Service.

Share on Facebook
Share on Twitter
Please reload

Featured Review

U.S. Healthcare Outlook

October 24, 2014

Please reload

Tag Cloud
Please reload

Gryphon Analytics Copyright 2012-2017

  • Grey Facebook Icon
  • Grey Twitter Icon
  • Grey Google+ Icon